drugset / Trial / NCT01701310
IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia
Phase 4
Completed
116 enrolled
Nottingham University Hospitals NHS Trust
National Institute for Health Research, United Kingdom · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
116 eligible patients with confirmed non-metastatic colorectal adenocarcinoma and anemia will be randomized to receive either oral ferrous sulphate (control) or intravenous ferric carboxymaltose (intervention). It is hypothesized that intravenous iron supplementation is more efficacious than oral iron therapy.
Timeline
- Start
- 2012-04
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferric carboxymaltose | Other / unclassified | 1000 mg | Intravenous |
| Comparator | Ferrous Sulfate | Diagnostic / imaging agent | 200 mg | Oral |